Novartis Ag (NVS) Debt Ratio (2009 - 2025)
Novartis Ag (NVS) posted Debt Ratio of 0.26 for Q4 2025, down 12.19% sequentially from 0.29 in Q2 2025, and up 20.3% YoY from 0.22 in Q4 2024.
Novartis Ag (NVS) Debt Ratio (2009 - 2025) Analysis & Trends
Novartis Ag (NVS) has 11 years of Debt Ratio data on file, last reported at 0.26 in Q4 2025.
- Quarterly Debt Ratio rose 20.3% year-over-year to 0.26 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.26 (up 20.3% YoY) and the FY2025 annual result came in at 0.26, up 20.3% from the prior year.
- Debt Ratio eased to 0.26 in Q4 2025 per NVS's latest filing, from 0.29 in the prior quarter.
- The five-year high for Debt Ratio was 0.29 in Q2 2025, with the low at 0.17 in Q2 2022.
- Average Debt Ratio over 5 years is 0.24, with a median of 0.23 recorded in 2022.
- Year-over-year, Debt Ratio plunged 37.03% in 2022 and surged 38.97% in 2023.
- Novartis Ag's Debt Ratio stood at 0.22 in 2021, then climbed by 0.6% to 0.22 in 2022, then decreased by 14.43% to 0.19 in 2023, then increased by 12.87% to 0.22 in 2024, then gained by 20.3% to 0.26 in 2025.
- Business Quant data shows NVS's Debt Ratio at 0.26 in Q4 2025, 0.29 in Q2 2025, and 0.22 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.37 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.27 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.47 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -0.21 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.31 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.26 |
| Jun 30, 2025 | 0.29 |
| Dec 31, 2024 | 0.21 |
| Jun 30, 2024 | 0.28 |
| Dec 31, 2023 | 0.19 |
| Jun 30, 2023 | 0.24 |
| Dec 31, 2022 | 0.22 |
| Jun 30, 2022 | 0.24 |
| Dec 31, 2021 | 0.22 |
| Jun 30, 2021 | 0.27 |
| Dec 31, 2020 | 0.22 |
| Jun 30, 2020 | 0.27 |
| Dec 31, 2019 | 0.18 |
| Jun 30, 2019 | 0.24 |
| Dec 31, 2018 | 0.16 |
| Jun 30, 2018 | 0.23 |
| Dec 31, 2017 | 0.18 |
| Dec 31, 2016 | 0.20 |
| Dec 31, 2015 | 0.17 |
| Dec 31, 2014 | 0.22 |